104 related articles for article (PubMed ID: 1058559)
1. Chronic myeloid leukaemia in Zambians.
Lowenthal MN
Trop Geogr Med; 1975 Jun; 27(2):132-6. PubMed ID: 1058559
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).
Ratanatharathorn V; Karanes C; Lum LG; Uberti J; Dan ME; de Planque MM; Schultz KR; Cronin S; Leisz MC; Mohamed A
Bone Marrow Transplant; 1992 Jan; 9(1):49-55. PubMed ID: 1543949
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
4. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
Sánchez Fayos J; Outeiriño J; de Villalobos E; Valera M; Alonso M; Calabuig MT; Paniagua G
Sangre (Barc); 1981; 26(1):65-71. PubMed ID: 6942520
[No Abstract] [Full Text] [Related]
5. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
Galimberti M; Polchi P; Lucarelli G; Angelucci E; Baronciani D; Giardini C; Gaziev D; Erer B; Ripalti M; Rapa S
Bone Marrow Transplant; 1994 Feb; 13(2):197-201. PubMed ID: 8205089
[TBL] [Abstract][Full Text] [Related]
6. Management of busulphan non-responsive chronic myeloid leukaemia.
Roul RK; Singh AD
J Indian Med Assoc; 1982 Aug; 79(3):27-9. PubMed ID: 6960081
[No Abstract] [Full Text] [Related]
7. Pregnancy in a patient receiving busulphan for chronic myeloid leukaemia.
Norhaya MR; Cheong SK; Hamidah NH; Ainoon O
Singapore Med J; 1994 Feb; 35(1):102-3. PubMed ID: 8009265
[TBL] [Abstract][Full Text] [Related]
8. [Varying course of pancytopenia after busulfan treatment of chronic myelocytic leukemia (CML)].
Krug K; Stenzel L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):181-7. PubMed ID: 79522
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
10. [Splenectomy for chronic myeloid leukaemia in the early and late phases (author's transl)].
Stolzenbach G; Garbrecht M; Delling G
Dtsch Med Wochenschr; 1977 Jun; 102(24):889-93. PubMed ID: 266988
[TBL] [Abstract][Full Text] [Related]
11. [High-dose busulfan with subsequent bone marrow transplantation in poor-risk forms of leukemia].
Urban C; Slavc I; Kaulfersch W; Teubl I
Wien Klin Wochenschr; 1987 Mar; 99(5):144-9. PubMed ID: 3554777
[TBL] [Abstract][Full Text] [Related]
12. [Indirubin in the treatment of chronic myelocytic leukemia (CML)--estimation of labelling index of bone marrow cells by 3H-TdR].
You YC; Mi JX; Wan JH; Yang TY; Wang ZC; Qian LS
Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):418-20. PubMed ID: 3482992
[TBL] [Abstract][Full Text] [Related]
13. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.
Cony-Makhoul P; Marit G; Boiron JM; Puntous M; Reiffers J
Bone Marrow Transplant; 1995 Jul; 16(1):69-70. PubMed ID: 7581131
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
15. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
Ionescu V
Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862
[No Abstract] [Full Text] [Related]
16. High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia.
Ferrara F; Palmieri S; De Simone M; Sagristani M; Viola A; Pocali B; Fasanaro A; Mele G
Br J Haematol; 2005 Jan; 128(2):234-41. PubMed ID: 15638859
[TBL] [Abstract][Full Text] [Related]
17. [Adrenal function in chronic myeloid leukemia].
Podolak-Dawidziak M; Silber-Kasprzak D
Acta Haematol Pol; 1976 OCT-DEC; 7(4):303-9. PubMed ID: 1069455
[TBL] [Abstract][Full Text] [Related]
18. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Wozniakowska
Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
[No Abstract] [Full Text] [Related]
19. Some biological and epidemiological characteristics of human leukaemia in Africans.
Williams CK
IARC Sci Publ; 1984; (63):687-712. PubMed ID: 6598802
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
Lu C; Braine HG; Kaizer H; Saral R; Tutschka PJ; Santos GW
Cancer Treat Rep; 1984 May; 68(5):711-7. PubMed ID: 6373004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
